MYO TECHNOLOGY Logo (WIPO, 04/29/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark MYO TECHNOLOGY was filed as Figurative mark on 04/29/2021 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Other geometrical figures, indefinable designs #Letters presenting a special form of writing #Series of letters in different dimensions
| Trademark form | Figurative mark |
| File reference | 1600080 |
| Countries | 
|
| Base trademark |
No. 90289629,
October 30, 2020
|
| Application date | April 29, 2021 |
| Expiration date | April 29, 2031 |
Trademark owner
30-02 48th Avenue
Long Island City NY 11101
US
Long Island City NY 11101
US
Trademark representatives
Morgan, Lewis & Bockius LLP,
One Federal Street
US
goods and services
05
Pharmaceutical preparations containing nucleic acid
sequences that encode monoclonal antibodies for the
treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders; pharmaceutical compositions for the prevention
and treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders; nucleic acid sequences for medical purposes;
pharmaceutical compositions, namely, a nucleotide sequence
that encodes an antigen, such as a DNA plasmid having an
antigen encoding sequence and like DNA, for the prevention
and treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders; pharmaceutical preparations for human use for the
treatment and prevention of cancer, autoimmune diseases,
rare diseases, infectious diseases, inflammatory diseases,
and blood disorders; pharmaceutical preparations for human
and veterinary use, namely, antibiotics, antifungals and
anti-virals; gene therapy and prophylactic products, namely,
gene delivery pharmaceuticals for the treatment of genetic
or cell based conditions
10
Medical apparatus for the administration of
biopharmaceuticals and vaccines, namely, drug delivery
devices and systems; medical devices, namely, for
electroporation mediated administration of drugs to humans
and animals; delivery systems for administration of
biopharmaceuticals and vaccines for the preventive or
treatment of disease in humans and animals; handheld medical
systems and devices using electroporation for the prevention
or treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders in humans and animals; handheld clinical delivery
systems and devices for the application of electrical fields
in tissue, in particular muscle and skin, in conjunction
with the administration of biopharmaceuticals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 18, 2023 | 2023/29 Gaz | CA | Rejection |
| January 25, 2023 | 2023/5 Gaz | BR | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| November 10, 2022 | 2022/46 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 4, 2022 | 2022/40 Gaz | CA | Rejection |
| August 2, 2022 | 2022/32 Gaz | BR | Rejection |
| May 26, 2022 | 2022/22 Gaz | JP | Rejection |
| March 3, 2022 | 2022/9 Gaz | GB | Rejection |
| February 15, 2022 | 2022/9 Gaz | IN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| December 1, 2021 | 2021/52 Gaz | CN | Rejection |
| November 24, 2021 | 2021/47 Gaz | EM | Rejection |
| September 21, 2021 | 2021/38 Gaz | AU | Rejection |
| July 20, 2021 | 2021/30 Gaz | IN | Rejection |
| April 29, 2021 | 2021/24 Gaz | US | Registration |
ID: 141600080